Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrimido[1′,6′: 1,5]pyrazolo[4,3-c] [2,7] naphthyridines as CK2 inhibitors

Pyrimido[1′,6′: 1,5]pyrazolo[4,3-c] [2,7] naphthyridines as CK2 inhibitors

US Patent 12209089 · Granted Jan 28, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrimido[4,5-b]indoles as CK2 inhibitors2025
Substituted pyrimido[4,5-b]indoles as CK2 inhibitors2025
7H-pyrido[4′,3′:4,5]pyrrolo[2,3-c][1,7]naphthyridine compounds as CK2 inhibitors2025
7H-pyrido[4′,3′:4,5]pyrrolo[2,3-c][1,7]naphthyridine compounds as CK2 inhibitors2025
Substituted pyrazino[1′,2′:1,5]pyrazolo[4,3-c][1,6]naphthyridines as CK2 inhibit2025
Substituted pyrazino[1′,2′:1,5]pyrazolo[4,3-c][1,6]naphthyridines as CK2 inhibit2025
Pyrrolo[3,2-c]isoquinoline-2,3-dione compounds as CK2 inhibitors2025
Pyrrolo[3,2-c]isoquinoline-2,3-dione compounds as CK2 inhibitors2025
Pyrido[3′,4′:4,5]pyrrolo[3,2-c]naphthyridine compounds as CK2 inhibitors2025
Pyrido[3′,4′:4,5]pyrrolo[3,2-c]naphthyridine compounds as CK2 inhibitors2025
Pyrazino[1′,2′:1,5]pyrazolo[4,3-c] [2,6] naphthyridine compounds as CK2 inhibito2025
Pyrazino[1′,2′:1,5]pyrazolo[4,3-c] [2,6] naphthyridine compounds as CK2 inhibito2025